Anzeige
Mehr »
Freitag, 09.01.2026 - Börsentäglich über 12.000 News
Fundamental stark, Kurs zu niedrig - Chance beim Krebs-Impfstoff-Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Cantech Letter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04.12.25Should you sell your Cardiol Therapeutics stock?
04.12.25Bombardier. Buy, Sell or Hold?
03.12.25Is Credo Technology stock a buy?
03.12.25This bull market is on solid footing, analyst says
03.12.25Should you sell your Crowdstrike stock?
02.12.25Avante. Buy, Sell or Hold?
02.12.25Buy Anaergia for a double, this analyst says
02.12.25Wishpond's turnaround will happen in 2026, this analyst says
02.12.25Is Toronto-Dominion Bank a value stock?
01.12.25This investor loves Boston Scientific
01.12.25Zoomd Technologies. Buy, Sell or Hold?
01.12.25Is Amazon Prime set to dominate sports?
30.11.25Should you sell your Starbucks stock?
30.11.25Canadians under 35 have a new worry, RBC says
28.11.25Should you sell your Zscaler stock?
28.11.25Can Imaflex's stock beat the market?
28.11.25This analyst loves Calian Group
28.11.25Should you sell your Telus stock?
27.11.25Should you sell your Nanalysis stock?
27.11.25Sabio Holdings is still a buy, this analyst says
26.11.25Meet the man behind Michael Burry's big AI short
26.11.25Shorters won't take down Capricor Therapeutics, this analyst says
26.11.25Is Semtech a buy right now?
25.11.25Here's what RBC thinks about Air Canada's stock right now
25.11.25Competition Bureau investigation into WELL Health is not a concern, Stifel says